{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:23:37Z","timestamp":1793118217322,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116610","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:49:55Z","timestamp":1730825395000},"page":"116610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P3","title":["Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in ob\/ob mice"],"prefix":"10.1016","volume":"230","author":[{"given":"Zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-na","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116610_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.bcp.2024.116610_b0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tem.2022.08.001","article-title":"NAFLD and thyroid function: pathophysiological and therapeutic considerations","volume":"33","author":"Hatziagelaki","year":"2022","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: The growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bcp.2024.116610_b0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.bcp.2024.116610_b0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(23)00159-0","article-title":"NASH drug treatment development: challenges and lessons","volume":"8","author":"Tilg","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116610_b0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2468-1253(21)00261-2","article-title":"Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review","volume":"7","author":"Mantovani","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.bcp.2024.116610_b0035","doi-asserted-by":"crossref","first-page":"e3668","DOI":"10.1002\/dmrr.3668","article-title":"Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis","volume":"39","author":"Ciccarelli","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.bcp.2024.116610_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.993562","article-title":"Daphnetin: A bioactive natural coumarin with diverse therapeutic potentials","volume":"13","author":"Javed","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116610_b0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/ddr.21920","article-title":"Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt\/\u03b2-catenin signaling pathway","volume":"83","author":"Liu","year":"2022","journal-title":"Drug Dev Res"},{"issue":"2","key":"10.1016\/j.bcp.2024.116610_b0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.etap.2014.08.004","article-title":"Umbelliferone and daphnetin ameliorate carbon tetrachloride-induced hepatotoxicity in rats via nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1 expression","volume":"38","author":"Mohamed","year":"2014","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0055","article-title":"Enhanced Keap1-Nrf2\/Trx-1 axis by daphnetin protects against oxidative stress-driven hepatotoxicity via inhibiting ASK1\/JNK and Txnip\/NLRP3 inflammasome activation","volume":"71","author":"Lv","year":"2020","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.bcp.2024.116610_b0060","first-page":"4673","article-title":"Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA-treated HepG2 cells","volume":"19","author":"Liu","year":"2019","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.bcp.2024.116610_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev Res"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0070","article-title":"Daphnetin ameliorates A\u03b2 pathogenesis via STAT3\/GFAP signaling in an APP\/PS1 double-transgenic mouse model of Alzheimer's disease","volume":"180","author":"Gao","year":"2022","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.bcp.2024.116610_b0075","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3390\/antiox11122365","article-title":"Daphnetin Alleviates Senile and Disuse Osteoporosis by Distinct Modulations of Bone Formation and Resorption","volume":"11","author":"Gao","year":"2022","journal-title":"Antioxidants (basel)"},{"issue":"11","key":"10.1016\/j.bcp.2024.116610_b0080","doi-asserted-by":"crossref","first-page":"2004507","DOI":"10.1002\/advs.202004507","article-title":"Hypermethylation of Hepatic Mitochondrial ND6 Provokes Systemic Insulin Resistance","volume":"8","author":"Cao","year":"2021","journal-title":"Adv Sci (weinh)"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12986-021-00595-8","article-title":"Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF\/MS","volume":"18","author":"Cai","year":"2021","journal-title":"Nutr Metab (lond)"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bcp.2024.116610_b0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semcdb.2019.10.007","article-title":"Cellular and molecular mechanisms of liver regeneration: Proliferation, growth, death and protection of hepatocytes","volume":"100","author":"Ozaki","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00125-006-0515-x","article-title":"Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes","volume":"50","author":"Sauma","year":"2007","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.bcp.2024.116610_b0105","doi-asserted-by":"crossref","first-page":"e202200261","DOI":"10.1002\/cbdv.202200261","article-title":"Daphnetin, a Coumarin in Genus Stellera Chamaejasme Linn: Chemistry, Bioactivity and Therapeutic Potential","volume":"19","author":"Hang","year":"2022","journal-title":"Chem Biodivers"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0110","article-title":"Daphnetin: A bioactive natural coumarin with diverse therapeutic potentials","volume":"13","author":"Javed","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bcp.2024.116610_b0115","unstructured":"Song D, Wei, X., Zhang, Y. Research Progress on Modern Pharmacy and Clinical Applications of Daphnetin. Journal of Trace Elements and Health Research 2022;39(04):(in Chinese)."},{"key":"10.1016\/j.bcp.2024.116610_b0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.intimp.2018.10.018","article-title":"Daphnetin protects against cisplatin-induced nephrotoxicity by inhibiting inflammatory and oxidative response","volume":"65","author":"Zhang","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"7\u20138","key":"10.1016\/j.bcp.2024.116610_b0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000513631","article-title":"Daphnetin Preconditioning Decreases Cardiac Injury and Susceptibility to Ventricular Arrhythmia following Ischaemia-Reperfusion through the TLR4\/MyD88\/NF-\u039ab Signalling Pathway","volume":"106","author":"Yang","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2024.116610_b0130","doi-asserted-by":"crossref","unstructured":"Fan X, Gao Y, Hua C, Peng L, Ci X. Daphnetin ameliorates PM2.5-induced airway inflammation by inhibiting NLRP3 inflammasome-mediated pyroptosis in CS-exposed mice. Biomed Pharmacother 2023;165:115047.","DOI":"10.1016\/j.biopha.2023.115047"},{"key":"10.1016\/j.bcp.2024.116610_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116857","article-title":"Chondroprotective and antiarthritic effects of Daphnetin used in vitro and in vivo osteoarthritis models","volume":"240","author":"Zhang","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2024.116610_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107601","article-title":"Daphnetin ameliorated GM-induced renal injury through the suppression of oxidative stress and apoptosis in mice","volume":"96","author":"Fan","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2024.116610_b0145","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1002\/jcb.27698","article-title":"Daphnetin protects hippocampal neurons from oxygen-glucose deprivation-induced injury","volume":"120","author":"Zhi","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bcp.2024.116610_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153465","article-title":"Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK\/Akt\/mTOR pathway in ovarian cancer","volume":"82","author":"Fan","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2024.116610_b0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phymed.2016.11.023","article-title":"7, 8-Dihydroxycoumarin (daphnetin) protects INS-1 pancreatic \u03b2-cells against streptozotocin-induced apoptosis","volume":"24","author":"Vinayagam","year":"2017","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.bcp.2024.116610_b0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s000110050622","article-title":"Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation","volume":"49","author":"Chinetti","year":"2000","journal-title":"Inflamm Res"},{"issue":"44","key":"10.1016\/j.bcp.2024.116610_b0165","doi-asserted-by":"crossref","first-page":"27412","DOI":"10.1073\/pnas.2002997117","article-title":"Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression","volume":"117","author":"Yang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bcp.2024.116610_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.03.003","article-title":"Lipid-Droplet Formation Drives Pathogenic Group 2 Innate Lymphoid Cells in Airway Inflammation","volume":"52","author":"Karagiannis","year":"2020","journal-title":"Immunity"},{"issue":"6945","key":"10.1016\/j.bcp.2024.116610_b0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature01763","article-title":"Transcription regulation and animal diversity","volume":"424","author":"Levine","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2024.116610_b0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2013.01.038","article-title":"Modification of enhancer chromatin: what, how, and why?","volume":"49","author":"Calo","year":"2013","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.bcp.2024.116610_b0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrg3863","article-title":"RNA-mediated epigenetic regulation of gene expression","volume":"16","author":"Holoch","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.bcp.2024.116610_b0190","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/hep.30559","article-title":"Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor \u03b3 in Mice","volume":"69","author":"Tong","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2005.09.002","article-title":"Non-alcoholic steatohepatitis: from cell biology to clinical practice","volume":"44","author":"Cortez-Pinto","year":"2006","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bcp.2024.116610_b0200","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/07853890510037383","article-title":"Fat in the liver and insulin resistance","volume":"37","author":"Yki-J\u00e4rvinen","year":"2005","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.bcp.2024.116610_b0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.bcp.2024.116610_b0210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bcp.2024.116610_b0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.21687","article-title":"Effects of rosiglitazone on the liver histology and mitochondrial function in ob\/ob mice","volume":"46","author":"Garc\u00eda-Ruiz","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2024.116610_b0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","article-title":"Thiazolidinediones and PPAR\u03b3 agonists: time for a reassessment","volume":"23","author":"Cariou","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bcp.2024.116610_b0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/CS20110373","article-title":"Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet","volume":"123","author":"Fraulob","year":"2012","journal-title":"Clin Sci (lond)"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0230","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2024.116610_b0235","doi-asserted-by":"crossref","first-page":"9735083","DOI":"10.1155\/2020\/9735083","article-title":"Loss of Hepatocyte-Specific PPAR\u03b3 Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet","volume":"2020","author":"Cordoba-Chacon","year":"2020","journal-title":"PPAR Res"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-16-0447","article-title":"Hepatocyte-specific, PPAR\u03b3-regulated mechanisms to promote steatosis in adult mice","volume":"232","author":"Wolf Greenstein","year":"2017","journal-title":"J Endocrinol"},{"issue":"8","key":"10.1016\/j.bcp.2024.116610_b0245","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Mor\u00e1n-Salvador","year":"2011","journal-title":"Faseb j"},{"issue":"5","key":"10.1016\/j.bcp.2024.116610_b0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"Matsusue","year":"2003","journal-title":"J Clin Invest"},{"issue":"36","key":"10.1016\/j.bcp.2024.116610_b0255","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bcp.2024.116610_b0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s10020-023-00740-4","article-title":"Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPAR\u03b3 transcriptional network in mice fed high fat diet","volume":"29","author":"Zhang","year":"2023","journal-title":"Mol Med"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224006105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224006105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T01:01:26Z","timestamp":1732928486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224006105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"alternative-id":["S0006295224006105"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116610","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in ob\/ob mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116610"}}